Background: Pulmonary embolism (PE) is a serious and preventable complication after surgery. Blood transfusion is a common event during surgery. The aim of the present study was to identify whether intraoperative blood product transfusions increase the risk of symptomatic post-operative PE. Methods: A retrospective, single-center case-control study at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University between 1 January 2013 and 31 December 2016 was performed. Adult hospitalized patients with confirmed symptomatic PE after surgery were defined as case group. Each patient was matched with two adult patients without symptomatic PE who underwent the same procedure on the same day or within one week. Perioperative data especially detailed blood transfusion was collected. Forward stepwise logistic regression analysis was performed. Results: During the study period, altogether 188,512 procedures were included, and postoperative PE were confirmed in 40 (0.02%) patients. Twelve (30.0%) case patients and 16 (20.0%) control patients received intra-operative blood transfusion. Intra-operative blood transfusion was revealed as a significant predictor for symptomatic post-operative PE (OR 80.669, 95% CI: 3.312-1,964.641, P=0.007), along with female sex (OR 86.921, 95% CI: 4.242-1,781.124, P=0.004), older age (OR 1.078, 95% CI: 1.005-1.156, P=0.035), longer length of stay before surgery (OR 1.124, 95% CI: 1.040-1.214, P=0.003) and longer operation time (OR 1.013, 95% CI: 1.002-1.025, P=0.024). Conclusions: Intra-operative blood transfusion was associated with an increased risk of symptomatic postoperative PE. PE prophylaxis and selective screening should be considered in patients who had received intra-operative blood transfusion, especially in female patients.
Introduction
Pulmonary embolism (PE) is the most common preventable cause of hospital death and the number-one strategy to improve patient safety in hospitals (1, 2) . It is well known that there is a high risk of PE after surgery (1, 2) . The incidence of perioperative PE varied by type of surgical procedure, 1.6% for general surgery, 1.5-2% for thoracic surgery, 0.7-30% for all orthopedic surgical procedures (3, 4) . In a postmortem study, mortality associated with postoperative PE is as high as 28 .9% (5) . Various factors for venous thromboembolism (VTE) have been well
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Intra-operative blood transfusion significantly increases the risk of post-operative pulmonary embolism established, including female sex, older age, active neoplasia, history of previous deep venous thrombosis (DVT) or PE, trauma, immobilization and infection (6) . There is a large amount of clinical data documenting the safety and efficacy of routine thromboprophylaxis in patients undergoing surgery (1, 7) . However, bleeding complications cannot be ignored (8, 9) . Moreover, even with aggressive VTE prophylaxis, this event sill occurs and suggests other undefined factors may play a role in VTE occurrence (10) .
Blood transfusion is a common event in patients undergoing surgery in an attempt to correct anemia and coagulation parameters during or after the operations. But Yeh et al. found that postoperative transfusion was associated with a worse outcome in pancreatic cancer patients with pancreaticoduodenectomy (11) . Moreover, blood transfusion is demonstrated to be associated with an increased risk of VTE in cancer patients, due to its proinflammatory and immunomodulatory nature (12, 13) . However, the effect of intra-operative blood transfusion and PE is less frequently described. So, the aim of our study was to evaluate whether intra-operative banked allogenic blood product transfusions increase the risk of symptomatic postoperative PE.
Methods

Patient population
We performed a retrospective study at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University between 1 January 2013 and 31 December 2016. Case subjects were in-hospital patients, aged over 18 years, with an objectively documented symptomatic PE after a surgical operation. The diagnostic criteria for PE were either: (I) a positive helical computed tomography with a central filling defect outlined by contrast material or a complete occlusion in a segmental or more proximal pulmonary artery; or (II) a pulmonary angiography with an intra luminal filling defect or a sharp cut-off in a vessel at least 2 mm in diameter. Patients who had previously diagnosed as PE or preoperatively diagnosed as symptomatic PE by helical computed tomography or pulmonary angiography were excluded. Forty clinically symptomatic and imaging-confirmed cases of PE after a surgical operation were identified. Each patient was then matched with two adult patients without symptomatic PE who underwent the same operation on the same day or within one week. If more than 3 patients had the same surgery on the same day, the nearest patients in the surgery opening time were chose. The same surgery is defined as having the same International Classification of Disease, 9 th Revision, Clinical Modification (ICD-9-CM) code. Although considered, age and sex were not included in the matching process. Matching on these parameters would prevent their use in the risk factor analysis.
Study design
A retrospective observational cohort study was used. We reviewed the medical records of all the patients in detail. Detailed blood transfusion data were collected on all transfused patients including product type and amount. Others including demographic, information on comorbid diseases, medications, surgical procedure, operative time, type of anesthesia, electrocautery and 30-day post-operation mortality during surgery were also recorded.
Statistical analysis
Continuous variables were described as means ± SD. Means were compared using Student's t-test. Medians and comparative analysis were executed with Mann-Whitney U test, Kruskal-Wallis test, or chi-square test when appropriate. Potential risk factors for perioperative thromboembolic events were assessed using conditional logistic regression, making use of the 1:2 matched-pair study design. All potential risk factors were evaluated by forward stepwise logistic regression analysis in a multivariate model (P for entry <0.05, for exit >0.10) used to identify perioperative predictors of PE. The results were reported as odds ratios (ORs) and 95% confidence intervals (95% CIs). All P values are 2-tailed and statistically significance was set at P<0.05. All statistical analyses were performed using the SPSS version 23.0.
Results
Between 1 January 2013 and 31 December 2016, there were 188,512 surgical operations, of which 40 patients (13 males and 27 females) satisfied criteria for postoperative PE, resulting in an incidence of 0.02%. Pulmonary emboli were recognized at 3.5 days (median; range, 1 to 46 days) after surgery. Almost all of the patients were documented by helical computed tomography, except one by pulmonary angiography. Of the 40 cases, 10 patients underwent abdomen surgery, 7 underwent gynecological surgery, 6 underwent orthopedic surgery, 6 underwent cardiovascular Table 1 . All patients did not have signs/symptoms of DVT before surgery. There were no differences in sex, age and intra-operative blood transfusion between the case patients and control patients. Twelve (30.0%) case patients received intra-operative blood transfusion. All of them received at least 2-unit transfusion of leukocyte-reduced red blood cell (RBC). Three patients transfused 1-unit platelet, at least 200 mL fresh frozen plasma (FFP) and RBC. Five patients transfused both FFP and RBC. Seven (58.3%) of the 12 case patients who received intra-operative blood transfusion were died. Among control patients, 16 (20.0%) received intra-operative blood transfusion. Four patients only received at least 1-unit leukocyte-reduced RBC and 1 patient only received 400 mL FFP transfusion. Two patients transfused 1-unit platelet, at least 200 mL FFP and at least 2-unit RBC. Nine patients transfused both FFP and RBC. One (6.3%) of the 16 control patients who received intra-operative blood transfusion was died. Hypertension and DVT after surgery were more frequent in case patients than in control patients (35.0% versus 16.3%, P=0.020; 15.0% versus 0.0%, P<0.001, respectively). In addition, Case patients had longer operating time and higher 30-day mortality (270.3±180.9 versus 212.3±127.5, P=0.044; 30.0% versus 1.3%, P<0.001, respectively).
By forward stepwise logistic regression analysis, intraoperative blood transfusion was demonstrated to be a significant predictor for PE after surgery (OR 80.669, 95% CI: 3.312-1,964.641, P=0.007) ( Table 2 ). Other independent risk factors for post-operative PE were female sex (OR 86.921, 95% CI: 4.242-1,781.124, P=0.004), older age (OR 1.078, 95% CI: 1.005-1.156, P=0.035), longer length of stay before surgery (OR 1.124, 95% CI: 1.040-1.214, P=0.003) and longer operation time (OR 1.013, 95% CI: 1.002-1.025, P=0.024).
Discussion
In this study, we reviewed cases of symptomatic PE after 188,512 consecutive surgeries at a single institution and found a low rate of symptomatic post-operative PE (0.02%). The median time between surgery and the diagnosis of PE was 3.5 days. This was consistent with other studies suggesting that PE mainly occurs during the first postoperative week (9, 14, 15) .
Blood product transfusions are frequently utilized during surgery. Intra-operative blood transfusion was demonstrated to be a significant risk factor for the development of PE in our study. The relationship between blood transfusion and development of VTE has been previously reported (16) (17) (18) (19) (20) . Rogers et al. found that transfusion of >4 U packed red blood cell (PRBC) preoperatively was independently associated with the development of VTE (16) . Xenos et al. reported that intra-operative PRBC blood transfusion was a significant risk factor for the development of VTE and the risk increased with increasing number of units transfused (17) . Among 1,070 patients undergoing cardiac surgery, intra-or post-operative PRBC transfusion is associated with increased risk of DVT in a dose-dependent fashion that is exacerbated when accompanied with FFP (18) . A study of women with stage IIIC-V adnexal or peritoneal cancer, postoperative FFP transfusion was associated with increased risk of DVT and PE (19) . Moreover, Nilsson et al. found that perioperative allogeneic blood transfusion was associated with an increase of developing VTE in women, but not in men (20) . In our study, female sex was also a significant risk factor for the development of PE. Thus, the surgeon maybe should weigh the risk and benefits of blood product transfusions in the perioperative period, especially in female patients.
There are many possible mechanisms that might explain for this phenomenon. Transfused blood, especially RBC blood transfusion can disrupt the balance of coagulation factors and modulates the inflammatory cascade (17) . Storage of red cells can be associated with an increase red cell aggregability and abnormal morphology which might contribute to blood flow disorders (21) . Normal mature RBCs do not interact with endothelium, but they become highly sticky when they have been stored longer, and this adhesion of vascular endothelium can contribute substantially to microvascular occlusions associated with thrombosis (22) . With prolonged storage, oxidative stress increases and results in lipid peroxidation, protein oxidation and reduced integrity of the erythrocyte membrane-all contributing to the formation of extra-cellular microvesicles or 'micro-particles (MP)' and hemolysis (23) . MPs are 0.1-1.0 µm in size and are released in blood flow by various types of cells (24) . Hemolysis release free hemoglobin and heme that are toxic to many cells and tissues (22) . Both MPs and hemolysis were associated with a reduction in vasodilation, platelet adhesion and aggregation, and exacerbation of inflammation (12, 23) . In addition, platelet MP might work synergistically with red-cell derived MP in mediating some transfusion-related thrombotic complications (25) . The addition of plasma may also affect the coagulation balance by adding pro-coagulants. Nitric oxide (NO) also has a fundamental role in vascular health by regulating vasodilation, compromising blood flow, inhibiting both platelet aggregation and endothelial adhesion molecule expression (23). Reynolds et al. found that banked blood is severely depleted in NO which may lead to augment thrombosis, microcirculatory perturbations or injury in susceptible hosts (23, 26) . Moreover, massive intra-operative blood transfusion might mean more blood loss, leading to increased use of hemostatic drugs and further deterioration of coagulation and thrombosis. Bed rest >3 days after surgery in our study was not associated with enhanced risk of PE development. However, longer length of stay before surgery was associated with increased risk of postoperative PE. Gillinov et al. also found prolonged preoperative bed rest as a risk factor for PE in the cardiac surgical patient (27) . Greaves et al. analyzed 242,670 patients undergoing colorectal surgery and found that preoperative hospitalization was an independent risk factor for VTE and each day of preoperative hospitalization increased the odds of VTE (28) . The longer preoperative period might contribute to the onset of PE by reducing mobility and causing venous stasis (28, 29) .
Limitations
This study had several limitations. First, this study was a case-control review with a relatively small sample size, which might influence its generalizability. Nonetheless, the effect size was strong enough that a statistically significant impact of these variables could be detected. Second, the lack of a strictly matched design between the two groups made it difficult to balance all confounding factors. Third, length of storage was not available. Therefore, we cannot comment on the effect of transfusion of older units on development of post-operative PE.
Conclusions
In this study, symptomatic PE occurred infrequently after surgery (0.02%). Intra-operative blood transfusion and female sex were associated with increased risk of symptomatic post-operative PE. PE prophylaxis and selective screening should be considered in patients who had received intra-operative blood transfusion, especially in female patients.
